What we do
Alliance Medical Group brings together imaging, radiopharmacy, radiotherapy, research delivery and data-led insight to support clinical research across international healthcare systems.
Our platform is designed for research that needs more than a single site or service. It connects radiopharmaceutical production, research-accredited imaging, clinical expertise, governance and patient recruitment in a controlled research environment.
This gives partners a clearer route from research concept to clinical delivery, whether the study involves a small patient group, a multi-centre trial or a multi-country programme.
research accredited PET-CT scanners
PET-CT scans delivered each year
radiopharmacy production units
cyclotrons across the current platform
Innovation in diagnostics needs access to accredited clinical environments, standardised imaging, reliable radiopharmacy supply and robust governance.
Alliance Medical Group supports clinical trials, imaging research, radiopharmaceutical development and AI-enabled innovation through established healthcare services operating across the United Kingdom, Italy, Ireland, Iberia, Northern Europe and Saudi Arabia.
This allows new technologies, tracers, therapies and pathways to be evaluated in controlled environments that reflect how diagnostics are delivered in practice.
Alliance Medical Group focuses on research where shared diagnostic infrastructure can accelerate development, improve evidence and support clinical adoption.
Our focus reflects the growing role of imaging and radiopharmacy in precision medicine, particularly where tracer availability, research-accredited imaging and patient recruitment need to work together:
Research into the next generation of tracers, theranostics and radiopharmaceuticals
Clinical trials involving radiopharmaceuticals, including phase I to III studies
Specialist imaging research, with a strong emphasis on PET-CT
Studies using novel or off-licence tracers and therapies
Investigator-initiated and sponsor-led research projects
AI and machine learning in image analysis
Molecular imaging and advanced PET-CT applications
Integration of research outcomes into clinical service development
Research creates value when it can be delivered, tested and adopted in real healthcare environments.
Alliance Medical Group connects the components many studies rely on: radiopharmaceutical production, imaging capacity, accredited scanners, clinical teams, governance and patient access.
For partners, this reduces the complexity of delivering research across multiple sites, countries and healthcare systems. It supports broader patient recruitment, creates opportunities to reach more diverse populations and gives research teams a platform that can scale from early-stage studies to larger clinical programmes.
Patient insight also has a role to play. Where appropriate, patient experience and pathway feedback can help shape research so that it remains connected to the people and services it is intended to benefit.
Alliance Medical’s clinical research platform supports local, multi-site and multi-country study delivery across the United Kingdom, Italy, Ireland, Iberia, Northern Europe and Saudi Arabia.
The platform brings together:
Cyclotron-based radiopharmacy production
PET-CT imaging infrastructure
Fixed and mobile research capability
Standardised imaging environments
Research-accredited scanners
Shared governance and quality frameworks
Multi-country patient recruitment capability
Pharmaceutical and biotech organisations
To support the development, evaluation and clinical adoption of novel tracers, theranostics and radiopharmaceuticals through connected imaging, radiopharmacy and research infrastructure.
Academic and research institutions
To access standardised imaging environments, specialist expertise and established clinical networks that support high-quality research and collaborative innovation.
Clinical trial sponsors and CROs
To simplify multi-site and multi-country study delivery through research-accredited imaging, coordinated governance and consistent operational standards.
Healthcare providers and research networks
To participate in clinical research within real-world healthcare environments, supporting patient recruitment, evidence generation and the integration of innovation into clinical practice.
Most organisations can provide part of the research pathway.
Alliance Medical Group brings together radiopharmaceutical development, research-accredited imaging, multi-country patient recruitment and shared governance within a single connected platform.
This helps reduce complexity, support consistent delivery and create opportunities to scale research from early-stage studies through to large multi-country clinical programmes.
Established in 1989, we employ over 4,500 experienced professionals dedicated to diagnostics.
We are a trusted partner to national health systems, an award‑winning provider of community diagnostic centres and the holder of the national PET‑CT contract in England, alongside a comprehensive private patient provision.
With twelve radiopharmaceutical production facilities internationally, we are at the forefront of advancing diagnostic solutions.
Delivering diagnostics
and insight at scale
